Kamada (KMDA) Non Operating Income (2012 - 2026)
Kamada's (KMDA) quarterly Non Operating Income came in at $1.6 million in Q1 2026, up 32.15% YoY from $1.2 million in Q1 2025, and up 32.15% on a QoQ basis from $1.2 million in Q1 2025.
Kamada (KMDA) Non Operating Income (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 14 years of Non Operating Income data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Non Operating Income rose 32.15% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 6.86% YoY) and the FY2025 annual result came in at $2.8 million, down 58.82% from the prior year.
- Non Operating Income improved to $1.6 million in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $2.6 million in Q4 2024 to a low of -$2.2 million in Q4 2023.
- A 4-year average of $778750.0 and a median of $1.4 million in 2025 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2024 — Non Operating Income jumped 216.5% — and 2026, when it soared 32.15%.
- Tracing KMDA's Non Operating Income over 4 years: stood at -$2.2 million in 2023, then jumped by 216.5% to $2.6 million in 2024, then sank by 54.87% to $1.2 million in 2025, then surged by 32.15% to $1.6 million in 2026.
- The last three Non Operating Income figures came in at $1.6 million (Q1 2026), $1.2 million (Q1 2025), and $2.6 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Kamada | 464.34 Mn | 434.87 Mn | 22.47 Mn | 679,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 679,000.00 |
| Mar 31, 2026 | 1.56 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 2.62 Mn |
| Dec 31, 2023 | -2.25 Mn |
| Dec 31, 2021 | 1.36 Mn |
| Dec 31, 2020 | 739,000.00 |
| Jun 30, 2020 | 1.42 Mn |
| Mar 31, 2020 | -774,000.00 |
| Dec 31, 2019 | -33,000.00 |
| Mar 31, 2019 | 156,000.00 |
| Dec 31, 2018 | -417,000.00 |
| Dec 31, 2017 | -122,000.00 |
| Mar 31, 2017 | 179,000.00 |
| Mar 31, 2016 | -128,000.00 |
| Dec 31, 2015 | 10,000.00 |
| Sep 30, 2015 | 611,000.00 |
| Jun 30, 2015 | -570,000.00 |
| Mar 31, 2015 | -447,000.00 |
| Dec 31, 2014 | 373,000.00 |